Results
138
Companies which are more than 50% undervalued based on analyst price target.
138 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
1299 | HK$54.25 | -0.8% | -11.0% | HK$580.3b | HK$93.05 | PE15.4x | E13.7% | 3.0% | Insurance | ||
1024 | HK$42.10 | 4.1% | 7.7% | HK$180.0b | HK$66.04 | PE11.2x | E16.7% | n/a | Media | ||
1876 | HK$7.10 | 2.2% | -42.2% | HK$93.6b | HK$11.05 | PE16.7x | E12.5% | 5.8% | Food, Beverage & Tobacco | ||
2313 | HK$58.65 | 1.7% | -15.9% | HK$88.2b | HK$90.59 | PE15.3x | E12.2% | 4.2% | Consumer Durables | ||
291 | HK$23.45 | 0.2% | -16.7% | HK$76.1b | HK$35.38 | PE13.6x | E8.3% | 3.3% | Food, Beverage & Tobacco | ||
1801 | HK$33.05 | 3.6% | 4.9% | HK$54.1b | HK$54.61 | PS6.8x | E44.1% | n/a | Pharmaceuticals & Biotech | ||
1093 | HK$4.46 | 1.8% | -22.3% | HK$51.3b | HK$7.11 | PE9.3x | E1.7% | 7.2% | Pharmaceuticals & Biotech | ||
1177 | HK$2.82 | -2.8% | 0.4% | HK$51.3b | HK$4.49 | PE22.3x | E12.8% | 2.1% | Pharmaceuticals & Biotech | ||
486 | HK$3.12 | -1.9% | 28.4% | HK$47.5b | HK$5.71 | PE14.3x | E100.1% | 0% | Materials | ||
3998 | HK$3.75 | 3.3% | 6.2% | HK$43.1b | HK$5.73 | PE12.2x | E13.0% | 6.5% | Consumer Durables | ||
656 | HK$4.25 | 1.9% | 3.7% | HK$34.8b | HK$7.50 | PE43.8x | E52.8% | 0.9% | Capital Goods | ||
881 | HK$12.28 | -2.2% | -6.5% | HK$29.1b | HK$18.60 | PE7.5x | E17.4% | 6.3% | Retail | ||
1548 | HK$10.68 | 4.3% | -17.6% | HK$22.9b | HK$22.68 | PS2.9x | E112.9% | 0% | Pharmaceuticals & Biotech | ||
1258 New | HK$5.09 | -3.4% | -7.6% | HK$19.9b | HK$7.97 | PE8.2x | E16.9% | 4.5% | Materials | ||
2228 | HK$5.20 | 6.1% | n/a | HK$17.7b | HK$9.92 | PS83.6x | E90.0% | n/a | Pharmaceuticals & Biotech | ||
867 | HK$7.02 | -2.2% | -37.3% | HK$17.0b | HK$11.00 | PE11.3x | E21.4% | 6.0% | Pharmaceuticals & Biotech | ||
2009 | HK$0.72 | 0% | 18.0% | HK$16.6b | HK$1.20 | PS0.06x | E68.9% | 3.7% | Materials | ||
6808 New | HK$1.70 | -4.5% | 77.1% | HK$16.2b | HK$2.60 | PS0.2x | E90.2% | 10.0% | Consumer Retailing | ||
2556 | HK$66.20 | 4.9% | n/a | HK$15.6b | HK$115.33 | PS10.5x | S28.0% | n/a | Software | ||
512 | HK$4.22 | -2.5% | 25.2% | HK$14.8b | HK$6.63 | PE6.1x | E2.3% | 6.2% | Pharmaceuticals & Biotech | ||
2145 New | HK$35.95 | -0.3% | 12.3% | HK$14.3b | HK$54.43 | PE17.5x | E23.3% | 4.5% | Household | ||
1833 | HK$6.13 | -0.6% | -45.2% | HK$13.2b | HK$12.45 | PS2.7x | E32.1% | 158.2% | Consumer Retailing | ||
9995 | HK$13.28 | -1.2% | -12.7% | HK$13.1b | HK$25.03 | PS4.4x | E51.9% | n/a | Pharmaceuticals & Biotech | ||
6826 | HK$24.80 | -0.2% | 7.2% | HK$12.7b | HK$42.57 | PE12.3x | E16.8% | 3.5% | Pharmaceuticals & Biotech |